Background:Sodium–glucose cotransporter-2 (SGLT2) inhibitors have the potential to alter the natural history of chronic kidney disease (CKD), and they should be included in cost-effectiveness analyses of screening for CKD.Objective:To determine the cost-effectiveness of adding population-wide screening for CKD.Design:Markov cohort model.Data Sources:NHANES (National Health and Nutrition Examination Survey), U.S. Centers for Medicare & Medicaid Services data,… Continue reading Population-Wide Screening for Chronic Kidney Disease
Tag: albuminuria
Visit-to-visit variability in albuminuria predicts renal function deterioration in patients with type 2 diabetes
Aims/IntroductionWe aimed to study the predictive ability of visit-to-visit variability in albuminuria for changes in renal function in patients with type 2 diabetes mellitus. Materials and MethodsThe cohort study was carried out in a single medical center. In the model development cohort of 1008 subjects, we developed the albuminuria variability score (AVS) to evaluate the visit-to-visit… Continue reading Visit-to-visit variability in albuminuria predicts renal function deterioration in patients with type 2 diabetes
2 Medical News 